Table 7: Antibacterial activity of purified product and antibiotic discs.


Inhibition zone of mm of

Clinical isolates 0.2 ml of conc. 30 mg/1.5 ml DEMSO m3.4in| Commercial antibiotic discs
MYN7 DOX NOR AUG OX OFX CZ
Klebsiella oxytoca m1 21 −ve 12 16 −ve 10 −ve
Enterobacter cancerogenus m2 14 −ve 11 25 −ve 12 −ve
P. aeruginosa m3 18 12 −ve 18 −ve 13 −ve
Citrobacter diversus m4 22 −ve 16 −ve −ve 11 −ve
Enterobacter agglomerans m5 21 −ve −ve 16 −ve −ve −ve
Klebsiella oxytoca m6 16 19 21 16 −ve 12 −ve
Enterobacter dissolvens m7 11 −ve 16 −ve −ve 24 −ve
Serratia fonticola m8 −ve 10 11 18 −ve 13 −ve
Escherichia coli m9 −ve −ve 11 20 −ve 11 −ve
Citrobacter freundii m10 22 19 19 18 12 14 −ve
Staphylococcus aureus m11 13 −ve −ve 17 −ve 10 −ve
Escherichia coli m12 −ve 10 26 −ve −ve 18 −ve
P. aeruginosa m13 13 19 23 18 −ve 16 −ve
Staphylococcus aureus m14 14 19 19 16 −ve 13 17
Bacillus cereus m15 −ve −ve 20 11 −ve 16 −ve

MYN7 = Purified product; NOR = Norfloxacin; Ox = Oxacillin; AUG = Augmentin; OFX = Ofloxacin; CZ = Cefazolin; DOX = Doxorubicin